ArticleAmerican journal of public health2009
The role of corporate credibility in legitimizing disease promotion.
Article in American journal of public health, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Document analysis of the Foundation for a Smoke-Free World's scientific outputs and activities: a case study in contemporary tobacco industry agnogenesis.Tobacco control · 2024Article
- Article
- Cigarette Packs With URLs Leading to Tobacco Company Websites: Content Analysis.Journal of medical Internet research · 2020Article
- The environmental externalities of tobacco manufacturing: A review of tobacco industry reporting.Ambio · 2020Review
- Revolution or redux? Assessing IQOS through a precursor product.Tobacco control · 2018Article
- "What Is Our Story?" Philip Morris's Changing Corporate Narrative.American journal of public health · 2015Article
- Exposing and addressing tobacco industry conduct in low-income and middle-income countries.Lancet (London, England) · 2015Article
- Who has used internal company documents for biomedical and public health research and where did they find them?PloS one · 2014Article
- The Limits of Corporate Social Responsibility: Techniques of Neutralization, Stakeholder Management and Political CSR.Journal of business ethics : JBE · 2013Article
- "The Big WHY": Philip Morris's failed search for corporate social value.American journal of public health · 2012Article
- Through tobacco industry eyes: civil society and the FCTC process from Philip Morris and British American Tobacco's perspectives.Tobacco control · 2012Article
- Planting trees without leaving home: tobacco company direct-to-consumer CSR efforts.Tobacco control · 2012Article
- Quid pro quo: tobacco companies and the black press.American journal of public health · 2012Article
- The effects of smoking-related television advertising on smoking and intentions to quit among adults in the United States: 1999-2007.American journal of public health · 2012Article
- Tobacco industry denormalisation as a tobacco control intervention: a review.Tobacco control · 2012Review
- Social responsibility in tobacco production? Tobacco companies' use of green supply chains to obscure the real costs of tobacco farming.Tobacco control · 2011Article
- Corporate social responsibility and access to policy élites: an analysis of tobacco industry documents.PLoS medicine · 2011Article
- The "We Card" program: tobacco industry "youth smoking prevention" as industry self-preservation.American journal of public health · 2010Article
- "Working the system"--British American tobacco's influence on the European union treaty and its implications for policy: an analysis of internal tobacco industry documents.PLoS medicine · 2010Article
- Turning negative into positive: public health mass media campaigns and negative advertising.Health education research · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
objectivesWe explored what corporate "credibility" means to tobacco companies to determine why it matters to companies and what a lack of credibility means to them.
methodsWe collected documents from an online tobacco industry document archive and analyzed them with an interpretive approach.
resultsTobacco companies conceptualized credibility not as being worthy of belief or confidence but as inspiring it. Thus, credibility was understood primarily as altering public perception of the industry. "Truth" was largely absent from tobacco industry conceptualizations of credibility, which were linked with "responsibility" and "reasonableness." However, industry research found that the public regarded credibility and responsibility differently, expecting these to entail truth telling, advertising reductions, less harmful products, apologies for deception, making amends, or exiting the tobacco business altogether. Overall, industry credibility-building projects failed repeatedly.
conclusionsPublic health discourse increasingly attends to the roles of corporations in promoting disease. Industries such as tobacco and alcohol have been identified as profiting from harmful products. Yet corporations' ability to continue business as usual requires sustaining an implicit societal assent to their activities that depends on corporate credibility. For public health to address corporate disease promotion effectively, undermining corporate credibility may be strategically important.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.